Poster Presentation Agenda
Preliminary Program
- - Welcome Address (Main Hall)
- - Genetic engineering of hematopoietic stem cells for the treatment of cancer (Main Hall)
- - Immunotherapy of Glioblastoma with Metabolically Empowered CAR T-cells (Main Hall)
- - Enhancing T cell Generation and Optimization for Patient Therapies (Main Hall)
- - CAR-T cells immunotherapy: The science of today is the therapy of tomorrow (Main Hall)
- - Ligand-based approach to CAR therapy (Main Hall)
- - Expression of modified FcyRI in T cells enables efficient ADCC and overcome the inherent limitations of CAR-T cells in solid cancers (Main Hall)
- - Identification of TCRs against recurrent mutations in uveal melanoma (Main Hall)
- - Lymphodepleting chemotherapy enhances neoantigen presentation and TCR-T Efficacy (Main Hall)
- - Quantifying Allele-specific CRISPR Editing Activity with CRISPECTOR2.0 (Main Hall)
- - Developing Stem Cell Transplantation in Hexacorallians; Toward Cell-Therapy for Corals (Main Hall)
- - Continuous B Cell Destruction and Regeneration: A Critical Aspect of Effective Anti CD19 CAR-T Cell Therapy (Main Hall)
- - NurExone`s Novel Exosome-Based siRNA Therapy: Advancing Spinal Cord Injury Treatment with FDA-Supported Progress and Pipeline Expansion in Neuronal Regeneration (Main Hall)
- - Circular RNA: Transforming a Promising Technology into Cutting-Edge Therapeutics (Main Hall)
- - T cell engineering using V(D)J recombination allows tumor growth inhibition in mice (Main Hall)
- - Effect of Apoptotic Cells and CAR T Cell Therapies Against Peritoneal Solid Tumors (Main Hall,Exhibition Hall)
- - Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma using CD38-Targeted Lipid Nanoparticles (Main Hall,Exhibition Hall)
- - Gene Therapy Addressing Deafness and Vestibular Areflexia in Clic5 Mutant Mice (Main Hall,Exhibition Hall)
- - Can Stem Cell-Derived Islet Cell Transplantation Replace Insulin Therapy in Type 1 Diabetes Management? (Main Hall,Exhibition Hall)
- - Personalized Antisense Oligonucleotides for ultra-rare diseases (Main Hall)
- - Targeting RNA splicing to regulate the anti cancer immune response (Main Hall)
- - Closing Remarks (Main Hall)
Poster Presentation Agenda
- - Poster Presentation
